Association for Accessible Medicines v. Keith M. Ellison

140 F.4th 957 · United States Court of Appeals for the Eighth Circuit · June 12, 2025 · No. 24-1019

Summary

The Eighth Circuit affirmed a district court's grant of a preliminary injunction against Minnesota's prescription drug price regulation statute. The court held that the state law likely violates the dormant Commerce Clause because it has the impermissible extraterritorial effect of controlling out-of-state drug transaction prices. The panel found that the plaintiff trade association was likely to succeed on the merits and that the balance of harms favored maintaining the injunction.

Court
United States Court of Appeals for the Eighth Circuit
Writing for the Court
COLLOTON; GRUENDER; KOBES
Jurisdiction
United States Court of Appeals for the Eighth Circuit
Decision date
June 12, 2025
Docket number
24-1019
Procedural posture
Appeal from United States District Court for the District of Minnesota
Standard of review
de novo for legal conclusions; abuse of discretion for preliminary injunction
Precedential value
published
Parties
Keith M. Ellison, Attorney General of Minnesota v. Association for Accessible Medicines
Disposition
affirmed

Topics

dormant commerce clausefederalisminterstate disputesappellate procedurecommercial

Practice areas

constitutional lawhealth lawcommercial litigation

Questions Presented

  1. Whether Minnesota Stat. §62J.842 violates the dormant Commerce Clause by having an impermissible extraterritorial effect on out‑of‑state manufacturers' prices
  2. Whether the district court abused its discretion in granting the preliminary injunction

Holdings

  1. The Act violates the dormant Commerce Clause because it controls the price of out‑of‑state transactions, an impermissible extraterritorial effect; therefore the district court’s preliminary injunction is affirmed.
  2. The district court did not abuse its discretion; the preliminary injunction is affirmed.

Key quotations

Because our decision is predominantly one of determining whether the established facts fall within the relevant legal definition, albeit a constitutional definition, we apply a de novo standard of review in deciding whether there has been a violation of the commerce clause. (at 957)
The Court did not overturn “the rule that was applied in Baldwin and Healy,” preserving its precedent that a state violates the extraterritoriality principle when it enacts “price control or price affirmation statutes that tie[] the price of in-state products to out-of-state-prices.” (at 957)

Factual background

AAM is a trade organization of generic prescription‑drug manufacturers. Minnesota enacted Stat. §62J.842, prohibiting manufacturers from imposing excessive price increases on generic or off‑patent drugs sold in the state. None of AAM's member manufacturers are Minnesota entities, but the law would penalize out‑of‑state manufacturers whose drugs are sold into Minnesota, potentially controlling prices outside the state.

Procedural history

The district court granted AAM's motion for a preliminary injunction, finding the Minnesota Act likely violated the dormant Commerce Clause. AAM appealed the injunction.

Court Document

Open PDF
Loading document…